Cognitive rehabilitation group intervention for breast cancer survivors: Results of a randomized clinical trial

Psycho-Oncology

Volumn 24, Issue 11, 2015, Pages 1360-1367

  Ercoli, L M ^a,b   Petersen, L ^b   Hunter, A M ^a,b   Castellon, S A ^a,b,c   Kwan, L ^b   Kahn Mills, B A ^b   Embree, L M ^a,c   Cernin, P A ^a   Leuchter, A F ^a,b   Ganz, P A ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALPHA RHYTHM; ARTICLE; ASSESSMENT OF HUMANS; BECK DEPRESSION INVENTORY; BRAIN FUNCTION; BREAST CANCER; CANCER STAGING; CANCER SURVIVOR; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; COGNITIVE REHABILITATION; COMPARATIVE STUDY; CONTROLLED STUDY; DELAYED RECALL; DELTA RHYTHM; EFFECT SIZE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MEMORY SCORE; MIDDLE AGED; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT OF OWN FUNCTIONING INVENTORY; PHASE 2 CLINICAL TRIAL; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RECALL; REY AUDITORY VERBAL LEARNING TEST; SCORING SYSTEM; SELF REPORT; TIME SERIES ANALYSIS; WECHSLER TEST OF ADULT READING; AGED; BREAST NEOPLASMS; COGNITIVE DYSFUNCTION; COGNITIVE THERAPY; GROUP THERAPY; NEUROPSYCHOLOGICAL TEST; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; SURVIVOR; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; COGNITIVE DYSFUNCTION; COGNITIVE THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOTHERAPY, GROUP; SURVIVORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84946477237     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3769     Document Type: Article

References (38)

1. Hurria A, Somlo G, Ahles T,. Renaming Chemobrain. Cancer Invest 2007; 25 (6): 373-377.
2. Schilder CM, Seynaeve C, Beex LV, et al,. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol 2010; 28 (8): 1294-1300.
3. Ahles TA, Saykin AJ,. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007; 7 (3): 192-201.
4. Janelsins MC, Kohli S, Mohile S, Usuki K, Ahles TA, Morrow GR,. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 2011; 38 (3): 431-438.
5. Reid-Arndt SA, Yee A, Perry MC, Hsieh C,. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. Journal of Psycho-Oncology 2009; 27 (4): 415-434.
6. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA,. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective randomized longitudinal trial. Cancer 2004; 100 (11): 2292-2299.
7. Wefel JS, Schagen SB,. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 2012; 12 (3): 267-275.
8. Ercoli LM, Castellon SA, Hunter AM, et al,. Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging Behav 2013; 7 (4): 543-553.
9. Chelune GJ, Heaton RK, Lehman RAW,. Neuropsychological and personality correlates of patients' complaints of disability. In Advances in clinical neuropsychology, Tarter G, Goldstein G, (eds.), Vol. 3. Plenum Press: New York, 1986; 95-126.
10. Burnam AM, Wells KB, Leake B, Landsverk J,. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988; 26 (8): 775-789.
11. O'Brien AR, Chiaravalloti N, Goverover Y, DeLuca J,. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature. Arch Phys Med Rehabil 2008; 89 (4): 761-769.
12. Levine B, Robertson IH, Clare L, et al,. Rehabilitation of executive functioning: an experimental-clinical validation of goal management training. J Int Neuropsychol Soc 2000; 6 (3): 299-312.
13. Moore Sohlberg M, Mateer CA,. Cognitive rehabilitation: an integrative neuropsychological approach. Guilford Press: New York, 2001.
14. White HA, Shah P,. Training attention-switching ability in adults with ADHD. J Atten Disord 2006; 10 (1): 44-53.
15. Wilson B,. Neuropsychological rehabilitation: theory and practice. Psychology Press: New York, 2003.
16. Bender CM, Pacella ML, Sereika SM, et al,. What do perceived cognitive problems reflect? J Support Oncol 2008; 6 (5): 238-242.
17. Ganz PA, Kwan L, Castellon SA, et al,. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst 2013; 105 (11): 791-801.
18. Beck AT, Steer RA, Brown GK,. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation. 1996.
19. Benedict RHB,. Brief Visuospatial Memory Test - Revised: Professional Manual. Psychological Assessment Resources Inc.: Odessa Florida, 1997.
20. Rey A,. L'examen Clinique en psychologie. Paris: Universitaires de France, 1964.
21. Spreen O, Strauss E,. A Compendium of Neuropsychological Tests (2nd edn). Oxford University Press: New York, 1998.
22. Gronwall DMA,. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 1977; 44: 367-373.
23. Reitan RM,. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-276.
24. Gualtieri CT, Johnson LG,. Reliability and validity of a computerized neurocognitive test battery CNS Vital Signs. Arch Clin Neuropsychol 2006; 21 (7): 623-643.
25. Brandt J, Benedict RHB,. Hopkins Verbal Learning Test-Revised. Professional manual. Lutz, FL: Psychological Assessment Resources, Inc. 2001.
26. Psychological Corporation. Wechsler Test of Adult Reading (WTAR). The Psychological Corporation: San Antonio TX, 2001.
27. Hunter AM, Kwan L, Ercoli LM, et al,. Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology 2014. DOI: 10.1002/pon.3487.
28. Cook IA, Leuchter AF, Uijtdehaage SH, et al,. Altered cerebral energy utilization in late life depression. J Affect Disord 1998; 49 (2): 89-99.
29. Ganz PA, Kwan L, Castellon SA, et al,. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst 2013; 105 (11): 791-801.
30. Cherrier MM, Anderson K, David D, et al,. A randomized trial of cognitive rehabilitation in cancer survivors. Life Sci 2013; 93 (17): 617-622.
31. Ferguson RJ, McDonald BC, Rocque MA, et al,. Development of CBT for chemotherapy-related cognitive change: results of a wait-list control trial. Psychooncology 2012; 21 (2): 176-186.
32. Schuurs A, Green HJ,. A feasibility study of group cognitive rehabilitation for cancer survivors: enhancing cognitive function and quality of life. Psychooncology 2012; 22 (5): 1043-1049.
33. Von Ah D, Carpenter JS, Saykin A, et al,. Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat 2012; 135 (3): 799-809.
34. Kesler S, Hadi Hosseini SM, Heckler C, et al,. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer 2013; 13 (4): 299-306.
35. Ahles TA, Root JC, Ryan EL,. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 2012; 30 (30): 3675-3686.
36. Babiloni C, Vecchio F, Lizio R, et al,. Resting state cortical rhythms in mild cognitive impairment and Alzheimer's disease: electroencephalographic evidence. J Alzheimers Dis 2011; 26 (Suppl 3): 201-214.
37. Ahles TA, Saykin AJ, McDonald BC, et al,. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 2010; 28 (29): 4434-4010.
38. Quesnel C, Savard J, Ivers H,. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 2009; 116: 113-123.